免疫肿瘤治疗药物的临床开发
Clinical development of immuno-oncology therapeutics.
66.6分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Clinical development of immuno-oncology therapeutics.
Cancer/testis antigens: from serology to mRNA cancer vaccine.
MST1R as a potential new target antigen of chimeric antigen receptor T cells to treat solid tumors.
共 3 条
MEMBER ACCOUNT
登录成功会直接打开下一页。